Page last updated: 2024-12-06

bathocuproine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bathocuproine (2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline) is a chelating agent that forms a highly colored complex with cuprous ions. It is widely used in analytical chemistry for the spectrophotometric determination of copper. Bathocuproine is synthesized by the condensation of 2,9-dimethyl-1,10-phenanthroline with benzaldehyde in the presence of a base. It is also used in various applications, such as in the detection of copper in biological samples, the study of copper-containing enzymes, and the development of novel copper-based sensors.'

bathocuproine: reagent for copper; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65149
CHEMBL ID220061
SCHEMBL ID36914
MeSH IDM0043076

Synonyms (51)

Synonym
nsc89195
4733-39-5
2,7-diphenyl-1,10-phenanthroline
1, 2,9-dimethyl-4,7-diphenyl-
nsc-89195
BIDD:GT0563
EU-0070645
OPREA1_173365
bathocuproine
bathocuproine, 96%
einecs 225-240-5
2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline
1,10-phenanthroline, 2,9-dimethyl-4,7-diphenyl-
nsc 89195
B-0380
D0711
b2694 ,
2,9-dimethyl-4,7-di(phenyl)-1,10-phenanthroline
inchi=1/c26h20n2/c1-17-15-23(19-9-5-3-6-10-19)21-13-14-22-24(20-11-7-4-8-12-20)16-18(2)28-26(22)25(21)27-17/h3-16h,1-2h3
sttgyiuespwxow-uhfffaoysa-
CHEMBL220061
AKOS005145736
unii-9thp2v94fx
9thp2v94fx ,
A827186
AM62655
FT-0622591
bathocuproine [mi]
SCHEMBL36914
DTXSID4063585
2, 9-dimethyl-4, 7-diphenyl-1, 10-phenanthroline
4, 7-diphenyl-2, 9-dimethyl-1, 10-phenanthroline
2,9,-dimethyl-4,7-diphenyl-1,10-phenanthroline
bathocuproin
J-610069
4,7-diphenyl-2,9-dimethyl-1,10-phenanthroline
AC-24458
mfcd00004972
bathocuproine, sublimed grade, 99.99% trace metals basis
CS-D1200
2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline;bathocuproin;2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline;2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline [bcp]
DS-4182
SY010658
8-hydroxy-quinoline-2-carboxylicacidmethylester
bathocuproine (purified by sublimation)
BCP11188
O10635
Q27273191
YSSJ00331
2.9-dimethyl-4.7-diphenyl-1.10-phenanthroline
2,9-dimethyl-4,7-diphenyl-1,10-phenantroline

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" This study could provide an insight into the safe usage of DTIC."( Mechanism of UVA-dependent DNA damage induced by an antitumor drug dacarbazine in relation to its photogenotoxicity.
Hiraku, Y; Iwamoto, T; Kawanishi, S; Okuda, M, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID276763Cytotoxicity against mouse ScN2a cells up to 1 uM2006Bioorganic & medicinal chemistry letters, Dec-01, Volume: 16, Issue:23
Metal complexes with superoxide dismutase-like activity as candidates for anti-prion drug.
AID276761Inhibition of PrP-res formation in mouse ScN2a cells relative to control2006Bioorganic & medicinal chemistry letters, Dec-01, Volume: 16, Issue:23
Metal complexes with superoxide dismutase-like activity as candidates for anti-prion drug.
AID276764Cytotoxicity against prion Fukuoka1 strain infected mouse N2a#58 cells up to 1uM2006Bioorganic & medicinal chemistry letters, Dec-01, Volume: 16, Issue:23
Metal complexes with superoxide dismutase-like activity as candidates for anti-prion drug.
AID276762Inhibition of PrP-res formation in prion Fukuoka1 strain infected mouse N2a#58 cells relative to control2006Bioorganic & medicinal chemistry letters, Dec-01, Volume: 16, Issue:23
Metal complexes with superoxide dismutase-like activity as candidates for anti-prion drug.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (98)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (2.04)18.7374
1990's28 (28.57)18.2507
2000's51 (52.04)29.6817
2010's15 (15.31)24.3611
2020's2 (2.04)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.07 (24.57)
Research Supply Index4.60 (2.92)
Research Growth Index5.81 (4.65)
Search Engine Demand Index55.12 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other98 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]